The prognostic significance of preoperative atrial fibrillation on mitral valve replacement remains unclear. The aim of this study was to explore the effects of the presence of preoperative atrial fibrillation on mortality and cardiovascular outcomes of mitral valve replacement for rheumatic valve disease.
INTRODUCTION
Current American College of Cardiology/American Heart Association (ACC/AHA) guidelines designate even asymptomatic patients with rheumatic mitral valve disease or patients with mild to moderate left ventricular (LV) dysfunction as a class I indication for mitral valve surgery [1] . Although patients with episodic or chronic atrial fibrillation (AF) are also recommended for surgical intervention [1] , the contribution of AF to the short-or long-term mortality rate and cardiovascular outcomes associated with valve surgery remains debated [2] [3] [4] [5] . In addition, most previous studies have focused on patients with degenerative mitral regurgitation rather than rheumatic valve disease, leaving the relationship between rheumatic mitral disease and atrial fibrillation less well defined.
Rheumatic valve disease remains an ongoing health problem in developing countries. Frequently, recurrent episodes of rheumatic inflammation can involve multiple valve components, which results in mitral annular dilatation, chordal elongation, valve leaflet fibrosis and mitral stenosis. The deformity of valve components and recurrence of rheumatic fever may adversely affect mitral valve repair, making the procedure technically more difficult and the result less stable than degenerative lesions of the mitral valve [6, 7] . As a result, most patients with rheumatic valve disease are referred for mitral valve replacement (MVR). Unfortunately, MVR is associated with higher mortality and incidence of thromboembolism complications. It is unclear whether preoperative AF, which has a high prevalence in patients with rheumatic heart disease, contributes to a high risk of cardiac death and cardiovascular outcomes of mechanical MVR. In the present study, therefore, we focused on a series of patients receiving mechanical MVR for isolated rheumatic valve disease and examined the influence of AF on short-and longterm morbidity and mortality.
PATIENTS AND METHODS

Patients
This study was approved by the Clinical Ethics Committee of Changhai hospital. Between January 1998 and December 2005, 1411 patients who suffered from rheumatic mitral valve disease, including mitral stenosis (MS), mitral regurgitation (MR) and both MS and MR, underwent MVR with mechanical prostheses. Of these, patients were excluded if they met one or more of the following criteria: (i) MVR performed with concomitant cardiovascular procedures comprising valve surgery (aortic valve or pulmonary valve surgery, tricuspid valve replacement, etc.) and procedures for congenital heart disease, as well as coronary artery and great vessel surgery; (ii) with previous cardiac surgeries or thoracic surgeries; (iii) intraoperative death; and (iv) with a stroke history. Overall, 793 patients were included in this study. According to the preoperative rhythm evaluated by electrocardiograph, patients in AF were assigned to the AF group, while patients in sinus rhythm (SR) were assigned to the SR group. Altogether, 503 patients were in the AF group and 290 in the SR group.
Perioperative management
All the patients underwent an approved informed consent to undergo MVR. Each patient underwent transthoracic echocardiography before surgery. Surgery was performed with the use of standard cardiopulmonary bypass. The mitral valve was exposed through a median sternotomy and a transseptal approach. 
Follow-up
Follow-up was performed by outpatient visits, as well as by telephone and written correspondence. Data gathered included survivorship, postoperative complications, LV function and tricuspid regurgitation (TR). Postoperative complications were comprehensively estimated by inquiry, physical examination and image appearance at outpatient review. Heart function at the end of follow-up was evaluated according to the New York Heart Association (NYHA) classification of congestive heart failure symptoms, and left ventricular ejection fraction (LVEF) was measured by echocardiography. The severity of TR was also evaluated by echocardiography and graded 1-4 as previously reported [8] . At least grade 3 was defined as significant TR. The follow-up rate until 30 December 2010 was 93.4% for a median of 8.33 years (range, 5.25-12.92 years).
If patients died during follow-up but underwent at least one evaluation, the results of the latest follow-up were included in the study analysis.
Definitions
In our study, we classified preoperative AF into paroxysmal and chronic AF. Chronic AF was defined as AF that persisted for more than 12 months. The cause of mortality was divided into cardiopulmonary-related deaths and all-cause deaths. Early mortality was defined as 30 day mortality. Late complications mainly included thromboembolism and anticoagulant-related haemorrhage. A thromboembolism complication was defined as a clinical manifestation of a cerebral, abdominal or peripheral infarct, with radiological correlation when indicated. Transient ischaemic attacks were not counted as strokes in this study. A haemorrhage event was defined as clinically significant bleeding that resulted in death, hospitalization, permanent injury or treatment with blood transfusion.
Statistical analysis
Student's t-test was used for the comparison of mean values between the AF and SR groups. Student's unpaired t-test was valid for approximately normally distributed data, whereas the Mann-Whitney U-test was used for non-normally distributed data. Categorical variables were compared between groups using Chi-squared or Fisher's exact test. Overall survival and late complications were demonstrated on the Kaplan-Meier curve and analysed using the log-rank test for the group difference. Cox multivariate analysis was used to assess the effect of preoperative rhythm, postoperative rhythm, age, NYHA class, LVEF, lower extremity oedema, TR and left atrial diameter. All the P values were two sided, and a value of P <0.05 was regarded as statistically significant. All data were processed by SPSS 18.0.
RESULTS
Patient characteristics
Pooled demographic data showed that patients in the AF group were older, had poorer LV function, a larger left atrium and more significant TR. Patients in this group also had a higher proportion of lower extremity oedema and left atrial plication. The distributions of other factors, such as sex, type of mitral valve disease, pulmonary systolic pressure, the techniques of tricuspid repair and the number of these repairs, were similar between the two groups ( Table 1) .
Postoperative mortality and morbidity
There were 33 early deaths, with a mortality of 4.2%, of which 22 were in the AF group and 11 in the SR group. The cause of death included low cardiac output syndrome (LCOS; n = 14), renal failure (n = 7), respiratory failure (n = 4), ventricular arrhythmias (n = 4), mediastinal infection (n = 2) and left ventricular rupture (n = 2). Short-term mortality in patients with preoperative AF was comparable to that of patients with preoperative SR (4.4 vs 3.4%; P = 0.579). One hundred and four cases experienced postoperative complications. Occurrence of LCOS was most common among postoperative complications. The incidence of ventricular arrhythmias and renal failure followed LCOS. Other complications occurred with a low incidence. A summary of postoperative complications is presented in Table 2 , with no significant difference in morbidity being observed between the two groups.
Long-term results
A total of 48 patients had late deaths, of whom 40 were in the AF group and eight in the SR group. The cause of late deaths included heart failure (n = 18), fatal haemorrhage (n = 12), thromboembolism (n = 7), cancer (n = 4), respiratory failure (n = 4) and other causes (n = 3). For patients in preoperative AF, 10 year survival from a Kaplan-Meier curve was 88.7%, compared with 96.6% in patients with preoperative SR (P = 0.002; Fig. 1 ). As the distribution of preoperative risk factors, such as age, LV function and TR, differed markedly between the two groups, we performed a Cox proportional hazards regression model to identify independent predictors for late deaths. As shown in Table 3 , old age, large left atrium, preoperative AF and low LVEF were significant adverse predictors for long-term mortality.
Late prosthetic valve endocarditis occurred in two patients, of whom one was in the AF group and the other in the SR group. There were no noteworthy differences between the two groups regarding the incidence of late prosthetic valve endocarditis. Fifty-six patients experienced thromboembolism complications by the end of follow-up, including 44 patients in the AF group and 12 in the SR group. Among the 44 thromboembolism complication cases in the AF group, cerebral infarctions occurred in 34 and peripheral infarctions in 10. The thromboembolism complications in the SR group were all cerebral infarctions. Seventy-three patients underwent a concomitant maze procedure and/or LAA ligation, of whom six underwent the maze procedure combined with LAA ligation, 15 underwent LAA ligation and 52 underwent the maze procedure. Four patients experienced thromboembolism complications among 73 patients who underwent the maze procedure and LAA ligation. As shown in Fig. 2 , freedom from thromboembolism complications at 13 years was lower for patients with preoperative AF without the maze procedure and LAA ligation compared with that for patients with preoperative SR without the maze procedure and LAA ligation and patients with a concomitant maze procedure and LAA ligation (76.3 vs 94.8 vs 94.0%, respectively; P = 0.001).
As shown in Table 4 , diabetes, large left atrium and preoperative AF were significant adverse predictors for thromboembolism complications, whereas the maze procedure was a protective factor for these complications. Anticoagulant-related haemorrhage occurred in 54 cases in the AF group and 30 cases in the SR group, with no statistically significant differences in the rate of freedom from haemorrhage at 13 years between the two groups (AF vs SR group: 80.4 vs 83.3%; P = 0.505) (Fig. 3) .
Both the AF and the SR groups had a significant improvement in NYHA class and LVEF at the end of follow-up. The proportion of NYHA class III-IV was 30.0% (78 of 260) in patients with preoperative SR and 35.1% (158 of 450) in patients with preoperative AF at a mean of 8.6 ± 2.4 years after surgery. Patients in NYHA class III-IV were not significantly different between the two groups (P = 0.164). The mean LVEF at 5 years after surgery was 59.4 and 66.8% in the AF and the SR group, respectively. Compared with preoperative echocardiographic data, LVEF measured at 5 years increased by an average of 1.2% in the AF group, while it increased by 5.3% in the SR group. The improvement of LVEF was more significant in patients in the SR group (P = 0.028). Postoperative rhythm also significantly influenced improvement of LVEF. The LVEF increased by an average of 0.8% in patients with postoperative AF, while it increased by 6.0% in patients with postoperative SR. The improvement of LVEF was more significant in patients with postoperative SR (P = 0.002). By use of multivariate analysis of logistical regression, preoperative LVEF, postoperative AF and postoperative TR were significant adverse predictors for low LVEF (<50%) measured at 5 years. The maze procedure was a protective factor for low LVEF. Preoperative AF was not an independent predictor for low LVEF (Table 5) .
At the end of follow-up, a total of 240 patients had significant TR, including 174 patients with preoperative AF and 66 with preoperative SR. The incidence of significant TR was higher in patients with preoperative AF compared with that in patients with preoperative SR (38.7 vs 25.4%; P <0.001). In addition, the TR volume at 5 years after surgery was also greater in patients with preoperative AF compared with those having preoperative SR (4.0 vs 3.5 ml; P = 0.017).
At late follow-up, a total of 369 patients had lower extremity oedema, of whom 36 had liver congestion. Ninety-two patients benefited from digoxin and/or diuretics (39 patients were treated with digoxin, 24 with diuretics and 29 with combination therapy). Of the remaining 277 patients, 110 were not taking digoxin or diuretics, and 167 did not experience relief from the symptom of lower extremity oedema, despite combination therapy. Lower extremity oedema was present in 34.8% of patients with preoperative SR and 61.9% of patients with preoperative AF. A higher proportion of lower extremity oedema presented in the AF group than the SR group (P < 0.001).
DISCUSSION
This study found a higher incidence of preoperative AF (63.4%) in patients with rheumatic mitral valve disease than was reported in a previous study on patients with non-rheumatic mitral regurgitation [9, 10] . Preoperative AF is a risk factor for long-term mortality, thromboembolism complications and tricuspid regurgitation, and it also has an adverse effect on the degree of improvement when considering LV function.
The results of this study demonstrate that AF has a high prevalence in patients with rheumatic heart valve disease. It is possible that the strong association observed between AF and rheumatic valve disease is partly determined by two factors. First, left atrial enlargement was more commonly seen in the AF group, probably induced by mitral valve pathology. Recurrence of rheumatic fever often leads to leaflet and chordal fibrosis and scarring, which is associated with restriction of leaflet motion and chordal fusion or shortening. Mitral valve pathologies, including stenosis and/or regurgitation, might be induced by deformity of the mitral valve components, which probably remodel the left atrium by enlarging the cavity. It is well known that left atrial enlargement is a predictor of AF [11] . Second, chronic rheumatic inflammation infiltrated the left atrial tissue. Recurrence of rheumatic inflammation could result in fibrosis and scarring in the left atrial tissue, which might act as a substrate for the development of AF [12, 13] .
Patients with valve disease in the compensated state might be asymptomatic or have mild symptoms. However, if AF becomes established, deterioration of left ventricular function may accelerate [5] . The duration of chronic AF increases in accord with the severity of left ventricular diastolic dysfunction, and the prognosis appears to worsen [14] . Chronic AF is also associated with TR [15] . The baseline demographics in this study identified that patients with preoperative AF had a higher NYHA class and a lower LVEF, as well as more significant TR compared with patients with preoperative SR. The onset of AF is not only a marker of disease severity, but also a decisive turning point in the progression of valve disease deterioration.
Most studies that have evaluated the influence of preoperative AF on the prognosis following cardiovascular surgical procedures have focused on coronary artery bypass grafting (CABG) and mitral valve repair. There is increasing evidence with regard to the impact of preoperative AF on the early and late outcomes of CABG. Regarding early outcomes of surgery, preoperative AF was weakly associated with short-term mortality [16] [17] [18] , but increased the risk of LCOS [17] . For late outcomes of surgery, preoperative AF was an independent predictor for long-term mortality and embolic complications [16] [17] [18] . The association of preoperative AF with short-and long-term mortality in patients undergoing mitral valve repair remains controversial. Previous studies have suggested that AF does not determine long-term survival, although early and late mortality in patients with preoperative AF was higher than that in patients with preoperative SR [4, 5] . In contrast, recent studies have demonstrated that pre- operative AF was an independent predictor for short-and longterm mortality after mitral valve repair [2, 3] . There remains little published evidence on the impact of AF on survival following MVR. In our study, patients with preoperative AF had lower survival rates at 10 years than those in preoperative SR (88.7 vs 96.6%). On multivariate analysis, preoperative AF was an independent adverse predictor for overall survival (hazard ratio = 1.574, P = 0.047). In a recent retrospective analysis incorporating 420 patients with valve replacements, there was no difference in 10 year mortality for patients with MVR with or without CABG between preoperative AF and preoperative SR cohorts. In fact, the SR cohort undergoing MVR with or without CABG experienced more frequent acute mitral regurgitation due to papillary muscle rupture or ischaemic dysfunction, which may explain the relatively poorer survival in the SR cohort compared with that in our study [19] .
Despite improvements in valve design, thromboembolism remains a major late complication of mechanical MVR. Based on the results of this study, the incidence of thromboembolism was significantly higher in the AF cohort. Previous studies have shown a high incidence of embolic complications in patients with preoperative AF, associated with a thrombus in the left atrium (specifically, the left atrial appendage) due to loss of atrial contractility [17] . Thus, closure of the left atrial appendage or reduction in the size of an enlarged left atrium was expected to reduce the incidence of late stroke. Unfortunately, a study of 812 patients with MVR showed that neither of these procedures prevented late stroke. However, a concomitant maze procedure did reduce the incidence of stroke [20] .
In our study, mechanical MVR was shown to improve LVEF significantly. Although no difference was observed in NYHA functional status after MVR between the AF and the SR group, the improvement of LVEF was more significant in patients with preoperative SR. A low LVEF in patients with preoperative AF may be related to loss of atrial contractility due to postoperative AF, which was correlated significantly with the duration of preoperative AF [21] . Persistent AF following valve surgery may have resulted in a persistent decrease in ventricular stroke volume of up to 20% [22] . In our study, postoperative AF was also indentified as a risk factor for low LVEF. Additionally, AF was closely associated with remodelling of the left ventricle, increased wall thickness, cavity enlargement and alteration of LV geometry into a more spherical shape after valve surgery [23] . This complex, adverse effect of AF may be a mechanism of ventricular dysfunction observed after valve surgery. A study by Kim et al. reported that AF may affect LV function after MVR for rheumatic mitral valve disease, and a concomitant maze procedure may improve LV function after surgery [24] .
Atrial fibrillation has been recognized as an important risk factor for the development of TR in patients with mitral valve disease, as well as for the persistence or occurrence of TR after mitral valve surgery. TR may increase right ventricular preload, which leads to the development of late heart failure. Patients with heart failure may therefore present with lower extremity oedema and hepatic congestion. Currently, preoperative AF is considered an indication for tricuspid valve repair [15] . However, a finding validated by Kim et al. showed that late TR may persist in either corrected or uncorrected mitral valve lesions, despite successful tricuspid valve repair. Kim and colleagues suggested that a concomitant maze surgery should be performed to inhibit the progression of TR over time [25] .
Traditionally, the timing of valve surgery has been decided on the basis of NYHA class. The increasing evidence regarding negative effects of preoperative AF on postoperative rhythm and valve surgery outcomes yields the following hypotheses. First, if the timing of valve surgery is based on rhythm status (regardless of NYHA class), early surgery in SR or soon after the onset of AF may prevent atrial remodelling, myocardial impairment and AF persistence. Second, valve surgery combined with surgical correction of AF may improve the early and late outcomes for preoperative chronic AF patients.
Unfortunately, the results of previous retrospective trials and our study cannot provide strong evidence in support of these hypotheses, because of limitations in patient demographics and incongruent concomitant surgical procedures. Thus, future prospective studies are needed to determine whether valve surgery before or soon after the onset of AF has a prognostic benefit, or whether concomitant procedures to reduce the incidence of AF contribute to a higher survival rate.
There are several limitations to our study. First, the factors predicting early and late mortality, such as age, NYHA class, LVEF and TR, were not evenly distributed among the baseline demographics of the AF and SR cohorts, which may have interfered with evaluation of the impact made by preoperative AF. Second, this study could not differentiate between effects of chronic vs paroxysmal AF. It is therefore unclear what effect, if any, paroxysmal AF may have on the outcome of valve surgery. Third, the rate of drop-out was 6.6%. If patients who experienced an adverse event did not receive follow-up, this may have affected the results of our study.
